30 and older, any sex, with Heart Failure. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Percent of Eligible Participants Who EnrollPrimary· 6 months
The investigators will assess enrollment success into the study among those considered eligible. Investigators aim to have at least 50% of eligible participants enroll into the trial.
Group
Value
95% CI
Patient and Companions
44
Mean Acceptability Checklist ScoreSecondary· Within 2 days after receiving checklist
The investigators will assess the perceived value of the checklist using a series of 11 questions developed for this study. Each question is scored using a 6-point Likert response scale where 1 = strongly disagree and 6 = strongly agree. Higher scores mean higher perceived value of the checklist.
Easier to talk to doctor
Group
Value
95% CI
Accompanied Patients
5.09
± 1.16
Companions
5.04
± 1.36
Unaccompanied Patients
4.86
± 1.46
Existing questions matched what I wanted to ask
Group
Value
95% CI
Accompanied Patients
5.35
± 1.30
Companions
5.13
± 1.42
Unaccompanied Patients
5.14
± 0.69
Adequate time in waiting room to finish checklist
Group
Value
95% CI
Accompanied Patients
5.48
± 1.20
Companions
5.52
± 1.20
Unaccompanied Patients
5.29
± 1.89
Easy to fill out
Group
Value
95% CI
Accompanied Patients
5.86
± 0.35
Companions
5.95
± 0.21
Unaccompanied Patients
6.00
± 0.00
Instructions clear and understandable
Group
Value
95% CI
Accompanied Patients
5.95
± 0.21
Companions
5.91
± 0.29
Unaccompanied Patients
5.29
± 1.89
Easy to use during discussion with Dr
Group
Value
95% CI
Accompanied Patients
5.89
± 0.32
Companions
5.94
± 0.24
Unaccompanied Patients
5.50
± 1.23
Would use checklist at next appt
Group
Value
95% CI
Accompanied Patients
5.00
± 1.75
Companions
5.12
± 1.58
Unaccompanied Patients
4.33
± 1.86
Checklist helped to get more questions asked
Group
Value
95% CI
Accompanied Patients
5.39
± 1.34
Companions
5.35
± 1.27
Unaccompanied Patients
4.83
± 1.60
Mean Score on the Self-Care of Heart Failure Index (SCHFI) - Management SubscaleSecondary· Up to 1 month after clinic visit
The SCHFI was used to measure self-care management. The 10-item self-care management scale assesses decision-making in response to HF symptoms. Of note, the self-care management questions are answered and scored only if the respondent endorses having experienced dyspnea or ankle swelling within the past month.The subscale score is standardized, with scores ranging from 0-100 (higher scores indicate greater self-care management). Scores ≥ 70 are reflective of "adequate" self-care management. A change in scale score of one-half of a standard deviation or more is considered clinically significant
Baseline
Group
Value
95% CI
Accompanied Patients
69.17
± 14.43
Unaccompanied Patients
66.25
± 6.29
1 Month Follow-Up
Group
Value
95% CI
Accompanied Patients
61.67
± 31.72
Unaccompanied Patients
62.50
± 6.45
Mean Score on the Self-Care of Heart Failure Index (SCHFI) - Maintenance SubscaleSecondary· Up to 1 month after clinic visit
The SCHFI was used to measure self-care maintenance. The 10-item self-care maintenance scale assesses behaviors used to maintain physiologic stability (e.g., adherence to medications, frequent weighing).This subscale score is standardized, with scores ranging from 0-100 (higher scores indicates greater self-care maintenance). Scores ≥ 70 are reflective of "adequate" self-care maintenance. A change in scale score of one-half of a standard deviation or more is considered clinically significant. Measured at Baseline and during the 1 Month Follow-Up.
Baseline
Group
Value
95% CI
Accompanied Patients
76.20
± 9.72
Unaccompanied Patients
81.10
± 12.76
1 Month Follow-Up
Group
Value
95% CI
Accompanied Patients
76.51
± 12.70
Unaccompanied Patients
76.66
± 9.43
Mean Score Self-Care of Heart Failure Index (SCHFI) F-Up Month 1 - Confidence SubscaleSecondary· Up to 1 month after
The 6-item subscale of the SCHFI was used to assess self-confidence in performing behaviors and making decisions to control heart failure symptoms. The subscale score is standardized, with scores ranging from 0-100 (higher scores indicates greater self-care confidence). Scores ≥ 70 are reflective of "adequate" self-care confidence. A change in scale score of one-half of a standard deviation or more is considered clinically significant. Measured at Baseline and during the 1 Month Follow-Up.
Baseline
Group
Value
95% CI
Accompanied Patients
67.48
± 19.44
Unaccompanied Patients
60.23
± 12.39
1 Month Follow-Up
Group
Value
95% CI
Accompanied Patients
70.51
± 15.67
Unaccompanied Patients
61.16
± 13.16
Mean Score on Caregiver Contribution to Self-Care of Heart Failure Index (CC-SCHFI) - Confidence SubscaleSecondary· Up to 1 month after.
The CC-SCHFI is a 22-item measure (across 3 sub-scales) that was used to assess the contribution of caregivers to the self-care maintenance and self-care management of HF patients as well as their confidence in their ability to contribute to the patients' HF self-care. This 6-item subscale uses a 4-point Likert scale (never or rarely, sometimes, frequently, always or daily), with a standardized score from 0 to 100; higher scores indicate higher confidence in ability to contribute to the patient's self-care. Measured at Baseline and during the 1 Month Follow-Up.
Baseline
Group
Value
95% CI
Companions
68.24
± 25.98
1 Month Follow-Up
Group
Value
95% CI
Companions
73.29
± 22.02
Mean Score on Caregiver Contribution to Self-Care of Heart Failure Index (CC-SCHFI) - Maintenance SubscaleSecondary· Up to 1 month after
The CC-SCHFI is a 22-item measure (across 3 sub-scales) that assesses the contribution of caregivers to the self-care maintenance and self-care management of HF patients as well as their confidence in their ability to contribute to the patients' HF self-care. This 10- item subscale uses a 4-point Likert scale (never or rarely, sometimes, frequently, always or daily), with a standardized score from 0 to 100; higher scores indicate higher contribution to self-care maintenance. Measured at Baseline and during the 1 Month Follow-Up.
Baseline
Group
Value
95% CI
Companions
57.72
± 23.37
1 Month Follow-Up
Group
Value
95% CI
Companions
57.42
± 26.18
Mean Score on Caregiver Contribution to Self-Care of Heart Failure Index (CC-SCHFI) - Management SubscaleSecondary· Up to 1 month after
The CC-SCHFI is a 22-item measure (across 3 sub-scales) that assesses the contribution of caregivers to the self-care maintenance and self-care management of HF patients as well as their confidence in their ability to contribute to the patients' HF self-care. This 6-item subscale uses a 4-point Likert scale (never or rarely, sometimes, frequently, always or daily), with a standardized score from 0 to 100; higher scores indicate higher contribution to the patient's self-care management. Measured at Baseline and during the 1 Month Follow-Up.
Baseline
Group
Value
95% CI
Companions
75.56
± 14.46
1 Month Follow-Up
Group
Value
95% CI
Companions
72.22
± 14.81
Mean Score on Perceived Efficacy in Patient-Physician Interactions (PEPPI)Secondary· Up to 1 month after clinic visit
The PEPPI is a 6-item measure which assesses confidence (self-efficacy) in communicating with health care providers. Each question is scored using a 5-point likert scale (0= not at all confident to 5=very confident). Higher scores indicate greater confidence in communicating with health care providers. Measured at Baseline, 2-Day Follow-Up, and during the 1 Month Follow-Up.
Baseline
Group
Value
95% CI
Accompanied Patients
3.68
± 0.32
Companions
3.83
± 0.31
Unaccompanied Patients
3.52
± 0.56
1 Month Follow-Up
Group
Value
95% CI
Accompanied Patients
3.76
± 0.29
Companions
3.81
± 0.33
Unaccompanied Patients
3.78
± 0.39
Mean Score on Communication With Physicians MeasureSecondary· Up to 1 month after clinic visit
The Communication with Physicians measure by Lorig was used. It is a 3-item measure assessing the frequency of patients' engagement in communication behaviors during medical visits, including, preparing a list of questions, asking questions about treatment, and discussing personal problems with provider. Each question is answered using a 6-point Likert scale ranging from 0=never to 5=always. Higher scores indicate more active engagement in communication during medical visits. Measured at Baseline and during the 1 Month Follow-Up.
Baseline
Group
Value
95% CI
Accompanied Patients
3.35
± 1.31
Unaccompanied Patients
3.00
± 1.66
1 Month Follow-Up
Group
Value
95% CI
Accompanied Patients
3.45
± 0.99
Unaccompanied Patients
2.72
± 0.98
Sponsor's own description
The purpose of this study is to conduct a pilot study in 30 Heart Failure (HF) patients and visit companions (i.e., a family member who accompanies the patient to medical visits), to evaluate a pre- visit question/topic prompt list, designed to enhance patient and family member engagement during visits by providing a list of questions or topics that they may want to discuss with their health care provider.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of North Carolina, Chapel Hill
Last refreshed: 22 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03491800.